Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

J. James Jenkins, Jr.

Member

Nashville
(615) 742-6236 TEL
(615) 742-2736 FAX

J. James Jenkins, Jr.

Member

Nashville
(615) 742-6236 TEL
(615) 742-2736 FAX
Nashville
(615) 742-6236 TEL
(615) 742-2736 FAX

Jim Jenkins has assisted clients in hundreds of transactions involving corporate mergers and acquisitions, and the acquisition and disposition of hospitals, surgery centers, managed care plans and physician group practices. Over the last 10 years, Jim has led deals with a combined value of over $25 billion.

His practice encompasses mergers and acquisitions of both public and private acquirors and targets, public equity and debt offerings, private placements of securities, and strategic relationships, such as joint ventures and corporate partnerships. Jim also provides advice on operational matters and counsels clients on a variety of other corporate and securities matters, including corporate governance.

Jim Jenkins has assisted clients in hundreds of transactions involving corporate mergers and acquisitions, and the acquisition and disposition of hospitals, surgery centers, managed care plans and physician group practices. Over the last 10 years, Jim has led deals with a combined value of over $25 billion.

His practice encompasses mergers and acquisitions of both public and private acquirors and targets, public equity and debt offerings, private placements of securities, and strategic relationships, such as joint ventures and corporate partnerships. Jim also provides advice on operational matters and counsels clients on a variety of other corporate and securities matters, including corporate governance.

His practice includes:

  • Healthcare Mergers, Acquisitions & Dispositions – Counseling on a wide variety of business combinations and other related transactions whether acquisitions, business combinations, joint ventures, strategic investments, syndications, restructurings, workouts or dispositions.
  • Healthcare Finance – Coordinating financing transactions for issuers, underwriters and purchasers including public debt and equity, private placements of securities and private equity investments.
  • Corporate Governance – Advising boards, directors, officers and other executives on contracting, regulatory, disclosure and operational concerns.

Jim currently serves on the firm's Executive Committee. Previously, he served as Chair of the firm's Healthcare Practice (2011-2015) and as the firm's hiring partner. 

+ Read More

- Read Less

Memberships

American Health Lawyers Association (AHLA)

Nashville Health Care Council — Leadership Health Care

News

View More

Representative Experience

View More

Additional Experience

Representative transactions include the following:

Merger and Acquisition Transactions

  • Represented a NASDAQ-listed healthcare services company in its $10.5 billion strategic merger transaction
  • Represented NASDAQ-listed healthcare services company in its $2.3 billion acquisition of a privately-held physician services business
  • Represented a NYSE-listed managed care company in its $7.2 billion strategic merger transaction
  • Represented a NYSE-listed managed care company in its $3.8 billion strategic merger transaction
  • Represented a NASDAQ-listed physician services company in the acquisition of multiple physician practices with a combined transaction value of our $1.5 billion
  • Represented a NASDAQ-listed operator of outpatient surgical facilities in over 150 acquisitions and joint ventures
  • Represented a privately-held hospital company in the acquisition of three acute care hospitals
  • Represented a NASDAQ-listed operator of outpatient surgical facilities in its $135 million acquisition of a privately-held company.
  • Represented a NYSE-listed managed care company in its $545 million acquisition of a privately-held managed care plan
  • Represented a NYSE-listed managed care company in its $405 million acquisition of a privately-held managed care plan
  • Represented a privately-held managed care company in a $435 million recapitalization transaction
  • Represented a NYSE-listed senior living company in its approximately $200 million acquisition of a privately-held senior living company

Public Securities Transactions

  • Represented a NASDAQ-listed healthcare services company in its offerings of common stock, preferred stock and senior notes generating proceeds in excess of $2.5 billion
  • Represented a NYSE-listed managed care company in its initial public offering of 21,620,000 shares of common stock and its public offering of 11,600,000 shares of common stock
  • Represented an owner and operator of hospitals in its $100.0 million offering of senior subordinated notes
  • Represented a NYSE-listed senior living company in its exchange of outstanding convertible subordinated debentures for a combination of newly issued senior subordinated notes and convertible subordinated notes
  • Represented a NYSE-listed managed care company in its public offering of 8,050,000 shares of common stock and its offering of $175.0 million of senior notes
  • Represented a NYSE-listed senior living company in its initial public offering of 3,593,750 shares of common stock and its public offerings of $138.0 million of convertible subordinated debentures and 4,500,000 shares of common stock

Publications

View More

Past Events

View More

Media Mentions

View More

Accolades

Chambers USA — Healthcare (2014-2016)

Best Lawyers in America® — Banking and Finance Law; Corporate Governance Law; Corporate Law; Health Care Law; Mergers and Acquisitions Law; Securities / Capital Markets Law (2007-2017)

Best Lawyers in America® — Nashville Securities / Capital Markets Law "Lawyer of the Year" (2017)

Nashville Medical News InCharge Healthcare (2014-2016)

Mid-South Super Lawyers "Rising Star" (2009)

SMU Law Review Association — Research Editor (1992-1994)

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.